{"id":45193,"date":"2022-06-17T08:01:39","date_gmt":"2022-06-17T06:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/"},"modified":"2022-06-17T08:01:39","modified_gmt":"2022-06-17T06:01:39","slug":"slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/","title":{"rendered":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France"},"content":{"rendered":"<div>\n<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated to the supply of innovative solutions in Cellular Biology, Immunology &amp; Molecular Biology, an expanding company with &gt;40 employees involved with sales, marketing &amp; scientific support. Ozyme relies on its organization &amp; the strong involvement of its personnel to serve efficiently the R&amp;D market. Ozyme is registered as an agreed supplier by the main public research Institutes &amp; key private companies.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/5\/primary_full_%282%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg\"><\/a><\/p>\n<p>\nThe agreement entitles Ozyme to the right to distribute and resell Slingshot Bio\u2019s products in France. Through Ozyme\u2019s network of customers, Slingshot Bio will be able to establish its presence in the France market with the well-established presence and expertise of Ozyme, which has been selling into flow cytometry for many years.\n<\/p>\n<p>\n\u201c<i>Ozyme\u2019s <\/i><i>network will provide us with the market penetration needed to reach our full sales potential. Slingshot Biosciences has considered many distribution partners and we are confident that Ozyme\u2019s extensive knowledge in the field, prominent presence, and large customer base will help us leverage our position in the flow cytometry market<\/i>,\u201d said Jeffrey Kim, CEO &amp; Founder.\n<\/p>\n<p>\nSlingshot Bio\u2019s synthetic cellular controls provide consistent, precise, and accurate control for research users in the flow cytometry space by mimicking blood properties as detected by flow cytometry. The ability to manufacture consistent controls for flow cytometry has been missing for decades and is now accurately reproducible with Slingshot Bio\u2019s unique manufacturing platform. Olivier Juffroy, Product Manager for Immunology stated, \u201cThe technology brought by Slingshot and Ozyme\u2019s expertise in flow cytometry is able to create a game changer: synthetic cells for setting the most accurate flow cytometry assays and get reliable results in conventional or spectral cytometry.\u201d\n<\/p>\n<p>\nAbout Slingshot Biosciences, Inc.\n<\/p>\n<p>\nFounded in 2012, Slingshot Biosciences is a fast-growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications\u2014including diagnostics, and adoptive cell therapy development and instrument calibration. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.slingshotbio.com&amp;esheet=52749903&amp;newsitemid=20220614006012&amp;lan=en-US&amp;anchor=www.slingshotbio.com&amp;index=1&amp;md5=1e3d9f355ce4f9af56176fef3692d689\" rel=\"nofollow noopener\" shape=\"rect\">www.slingshotbio.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nCaitlin Farquhar<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x40;&#115;&#x6c;&#105;&#x6e;&#103;&#x73;&#104;&#x6f;&#116;&#x62;&#105;&#x6f;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#64;&#x73;&#108;i&#x6e;&#x67;&#115;&#x68;&#x6f;&#116;b&#x69;&#111;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated to the supply of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45193","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated to the supply of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-17T06:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France\",\"datePublished\":\"2022-06-17T06:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/\"},\"wordCount\":396,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006012\\\/en\\\/1486799\\\/21\\\/primary_full_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/\",\"name\":\"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006012\\\/en\\\/1486799\\\/21\\\/primary_full_%282%29.jpg\",\"datePublished\":\"2022-06-17T06:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006012\\\/en\\\/1486799\\\/21\\\/primary_full_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614006012\\\/en\\\/1486799\\\/21\\\/primary_full_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/","og_locale":"en_US","og_type":"article","og_title":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend","og_description":"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated to the supply of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-17T06:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France","datePublished":"2022-06-17T06:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/"},"wordCount":396,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/","url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/","name":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg","datePublished":"2022-06-17T06:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220614006012\/en\/1486799\/21\/primary_full_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ozyme-to-distribute-synthetic-cells-throughout-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Slingshot Biosciences, Inc. Partners With Ozyme to Distribute Synthetic Cells Throughout France"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45193"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45193\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}